We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.25%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$684M
AUM Growth
-$28.6M
(-4%)
Cap. Flow
-$43.8M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
12.14%
Holding
440
New
109
Increased
100
Reduced
127
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LM
Legg Mason, Inc.
LM
|
+$5.96M |
| 2 |
Evercore
EVR
|
+$4.79M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.29M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$4.22M |
| 5 |
Avista
AVA
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$5.21M |
| 2 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$5.17M |
| 3 |
Southwest Gas
SWX
|
+$5.09M |
| 4 |
Sunstone Hotel Investors
SHO
|
+$4.25M |
| 5 |
HRG
HRG Group, Inc.
HRG
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.55% |
| 2 | Technology | 13.89% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 12.43% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPXC
276
DELISTED
RPX Corporation
RPXC
| $682K | 0.1% |
+48,886
| New | +$650K |
|
277
Houlihan Lokey
HLI
$8.77B
| $678K | 0.1% |
19,425
-1,615
| -8% | -$54.8K |
|
278
Rockwell Automation
ROK
$53.5B
| $662K | 0.1% |
+4,089
| New | +$645K |
|
|
MNTA
279
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $655K | 0.1% |
+38,738
| New | +$590K |
|
280
Darden Restaurants
DRI
$23.6B
| $648K | 0.09% |
+7,165
| New | +$626K |
|
281
Medpace
MEDP
$16B
| $634K | 0.09% |
21,879
-345
| -2% | -$9.68K |
|
|
PSB
282
DELISTED
PS Business Parks, Inc.
PSB
| $605K | 0.09% |
+4,573
| New | +$571K |
|
283
MillerKnoll
MLKN
$1.64B
| $573K | 0.08% |
18,856
+2,411
| +15% | +$76.8K |
|
284
Deckers Outdoor
DECK
$13.6B
| $568K | 0.08% |
+49,920
| New | +$521K |
|
285
Elevance Health
ELV
$83B
| $564K | 0.08% |
+2,999
| New | +$539K |
|
|
CONN
286
DELISTED
Conn's Inc.
CONN
| $552K | 0.08% |
+28,875
| New | +$467K |
|
287
PNC Financial Services
PNC
$100B
| $531K | 0.08% |
+4,254
| New | +$513K |
|
288
AES
AES
$10.5B
| $507K | 0.07% |
45,610
-65,128
| -59% | -$748K |
|
289
Associated Banc-Corp
ASB
$5.93B
| $497K | 0.07% |
19,712
-128,147
| -87% | -$3.15M |
|
290
Toll Brothers
TOL
$14.1B
| $494K | 0.07% |
12,502
-20,597
| -62% | -$769K |
|
291
Eli Lilly
LLY
$1,000B
| $483K | 0.07% |
+5,871
| New | +$479K |
|
292
Upbound Group
UPBD
$1.18B
| $483K | 0.07% |
41,203
-16,982
| -29% | -$192K |
|
|
MRC
293
DELISTED
MRC Global
MRC
| $466K | 0.07% |
+28,231
| New | +$517K |
|
|
CKH
294
DELISTED
Seacor Holdings Inc.
CKH
| $466K | 0.07% |
+14,037
| New | +$744K |
|
295
Phibro Animal Health
PAHC
$1.51B
| $463K | 0.07% |
12,487
-4,450
| -26% | -$145K |
|
296
Wolverine World Wide
WWW
$1.62B
| $462K | 0.07% |
16,489
-54,560
| -77% | -$1.38M |
|
|
SPTN
297
DELISTED
SpartanNash
SPTN
| $459K | 0.07% |
17,672
+1,660
| +10% | +$54.6K |
|
298
Preferred Bank
PFBC
$1.26B
| $454K | 0.07% |
+8,493
| New | +$438K |
|
299
United Natural Foods
UNFI
$2.87B
| $449K | 0.07% |
12,239
-1,852
| -13% | -$74.4K |
|
|
KLXI
300
DELISTED
KLX Inc.
KLXI
| $449K | 0.07% |
+10,638
| New | +$431K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
SPC
BGIM
Convergence Investment Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Convergence Investment Partners held 440 positions worth $684M, down 4% from $712M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Convergence Investment Partners withdrew a net $43.8M in Q2 2017, closing 102 positions and reducing 127 holdings. Its most notable exit was Darling Ingredients, an estimated $5.21M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Convergence Investment Partners opened a new position in Legg Mason, Inc. worth $6M.
- Convergence Investment Partners's largest Q2 2017 buy was Legg Mason, Inc.: 157,340 shares worth $6M.
- Convergence Investment Partners added most to Sabra Healthcare REIT in Q2 2017, an estimated $2.78M increase.
- Convergence Investment Partners's biggest Q2 2017 reduction was Sunstone Hotel Investors, cutting an estimated $4.25M.
- Convergence Investment Partners fully exited Darling Ingredients in Q2 2017, selling an estimated $5.21M.
- Convergence Investment Partners's ten largest holdings make up 12% of its $684M portfolio in Q2 2017.
- Convergence Investment Partners opened 109 new positions and closed 102 in Q2 2017.
- Convergence Investment Partners's portfolio value fell 4% quarter-over-quarter to $684M.
Based on Convergence Investment Partners's 13F filing for Q2 2017, filed 2 Aug 2017.